12 Posters and Presentations Featuring MolecuLight to be Presented at the SAWC Fall 2023 Conference
02 Nov 2023
Unprecedented Body of New Clinical Evidence using the MolecuLight Wound Imaging Platform Demonstrates Improved Clinical Decision-Making and Patient Outcomes
TORONTO and LAS VEGAS, Nov. 2, 2023 /PRNewswire/ -- MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of elevated bacterial loads in wounds, announces that MolecuLight data will be presented in 12 clinical posters and presentations at the Symposium on Advanced Wound Care (SAWC) Fall 2023. The results to be presented include new data from recent investigations using MolecuLight device from over 1,500 patients. The international conference is being hosted from November 2 - 5, 2023 in Las Vegas, Nevada, and is one of the largest multidisciplinary meetings of wound care professionals in the world.
"We are proud to see once again abundant and consistently favorable outcomes being presented by MolecuLight imaging platform users at this week's SAWC conference", says Anil Amlani, CEO of MolecuLight. "The volume of our clinical evidence continues to grow and confirms that MolecuLight improves healing outcomes. Our devices inform the appropriate use of antibiotics and help empower patients during the treatment and recovery of their wounds. We are particularly motivated by of our impactful clinical results in vulnerable patient populations that suffer from health care inequities. Our device has proven to be an equitable diagnostic tool that delivers quality results for patients of all skin tones. This sets us apart and makes us part of the solution, and we couldn't be more proud of this."
"Good wound hygiene is a game-changer for taking wound care to the next level and boosting those outcomes. I always say, 'Clean it like you mean it', but we can only clean what we can see. MolecuLight is an objective tool that, for the first time, allows providers to visualize in real-time and more effectively remove bacterial burden that is otherwise invisible to the naked eye," says Dot Weir, RN, CWON, CWS, wound care nurse at Saratoga Hospital Center for Wound Healing and Hyperbaric Medicine in Saratoga Springs, New York and Co-Chair of the Symposium on Advanced Wound Care (SAWC). Dot is speaking at a hands-on pre-conference workshop showing how MolecuLight can be used to guide and improve wound hygiene practices. "We can and should do better. The MolecuLight device is evidence-backed, equitable for all patients, and is instrumental in the care of every single patient who walks through our doors. This amazing piece of hand-held technology is revolutionizing the way we clean wounds. I can't imagine delivering the highest quality of care without it."
Continue Reading
Preview
Source: PRNewswire
12 Posters and Presentations Featuring MolecuLight to be presented at SAWC Fall 2023 (CNW Group/MolecuLight)
Preview
Source: PRNewswire
12 Posters and Presentations Featuring MolecuLight to be Presented at the SAWC Fall 2023 Conference (CNW Group/MolecuLight)
The clinical presentation and posters featuring the MolecuLight
i:X and
DX from SAWC Fall 2023 are as follows:
CLINICAL PRESENTATIONS
Hands-On Pre-Conference Workshop:
Wound Infection Day
Dot Weir (Saratoga Hospital Wound Healing Center) will be presenting cases and a hands-on workshop showing how the application of point-of-care fluorescence imaging can help guide wound hygiene practices.
Thursday, November 2, 2023, 1:00 PM – 5:00 PM, Julius 1-4
A Multidisciplinary Panel Looks at Debridement
Dot M. Weir, RN, CWON, CWS, Saratoga Hospital Wound Healing Center, Gansevoort, NY
Friday, November 3, 2023, 10:30 AM – 11:30 AM PDT, Milano I-III
Wound Imaging
Oscar M. Alvarez, PhD, CCT, FAPWCA, Rutgers, New Jersey Medical School
Saturday, November 4, 3:10 PM – 3:35 PM PDT, Milano I-III
New Wound Diagnostics
Charles A. Andersen, MD FACS, Chief of Vascular/Endovascular Surgery/Limb Preservation Service, Madigan Army Medical Center, Milton, WA
Saturday, November 4, 2023, 3:45 PM – 4:10 PM PDT, Milano I-III
Advanced Clinical Practice and Emerging Research (SAWC Oral Abstracts)
Multimodal imaging device for real-time bacterial load and thermal imaging: a study of synergy in clinical wound assessment workflow
Charles A. Andersen, MD
Vascular/Endovascular/Limb Preservation Surgery Service, Madigan Army Medical Center, WA
Saturday, November 4, 4:20 PM – 4:45 PM PDT, Julius 7-10
RAPID FIRE: Poster Oral Presentations (previously SAWC Poster Grand Rounds)
Pseudomonas Scrub Down: Advances in Wound Imaging Objectively Confirm the Efficacy of Acetic Acid
Against this Pathogen
Alisha Oropallo, MD1; Amit Rao, MD1; Angelin Mathew, BS2
Saturday, November 4, 5:00 PM – 6:00 PM PDT, Julius 7-10
Download poster
b)
CLINICAL
POSTERS
Poster#CS-086
Wounds Illuminated: Unveiling the Shades of Red Fluorescence
Charles A. Andersen1, Raymond J. Abdo2, Misael Alonso3, Katherine McLeod1, Nathan Krehbiel4, Ashley Jacob4
Download poster
Poster #PI-003
Strategies to improve equity in wound bacterial-infection assessments on skin of color
Charles Andersen1, Jonathan Johnson2, Alton R. Johnson Jr.3, Angelin Mathew, BS4
Download poster
Poster # CR-030
Co-localization of High Bacterial Load with Regions of Pain in Venous Leg Ulcers:
Imaging Informs Interventions and Validates Patient Self-Reported Pain
Amit Rao, MD1; Farisha Baksh, BS1; Sally Kaplan, RN1; Alisha Oropallo, MD1,2
Download poster
Poster #CR-035
Does bacterial fluorescence imaging improve chronic wound biofilm detection over standard clinical assessment and blotting?
Liis Teene, Laura M Jones*, Perry V. Mayer, Monique Y. Rennie, Hanna Varonina*, Ashley Jacob*, Phil Bowler
Download poster
Poster #CS-183
Enhancing Wound Bed Preparation: Combining Bacterial Load Imaging Detection Technology with a Hypochlorous Acid Preserved Cleanser
Dot Weir, Saratoga Hospital Wound Healing Center, Gansevoort, NY
Poster #EBP-011
Systemic and topical antimicrobial prescribing trends in outpatient wound care: Observational multi-centric study from 1447 baseline wound assessments and impact of Bacterial Fluorescence Imaging
Nancy Trafelet, SerenaGroup Advanced Wound Care & Hyperbaric Medicine, Cambridge, MA
In addition to the clinical posters and presentations at SAWC Fall 2023, the MolecuLight
i:X® and
DX™ imaging devices will be available for demonstration in the MolecuLight booth #430 in the Octavius Ballroom (Level 3) at Caesars Palace, Las Vegas, NV.
The MolecuLight
i:X® and
DX™ are the only imaging devices for the real-time detection of elevated bacterial burden in wounds that are FDA cleared and CE and Health Canada Approved. With unmatched clinical evidence including over 80 peer-reviewed publications and 2,600 patients, they are used by leading wound care facilities globally.
About MolecuLight Inc.
MolecuLight Inc. is a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight's suite of commercial devices, which include the MolecuLight
i:X® and
DX™ fluorescence imaging systems and their accessories, are point-of-care handheld imaging devices for the real-time detection and localization of bacterial load in wounds and digital wound measurement. MolecuLight procedures performed in the United States benefit from an available reimbursement pathway which includes two CPT® codes for physician work to perform "fluorescence imaging for bacterial presence, location, and load" and facility payment for
Hospital
Outpatient
Department (
HOPD) and
Ambulatory
Surgical
Center (
ASC) settings through an
Ambulatory
Payment
Classification (
APC) assignment. The company is also commercializing its unique fluorescence imaging platform technology for other global markets with relevant unmet needs in food safety, consumer cosmetics and other key industrial markets.
Rob Sandler, Chief Marketing Officer, MolecuLight Inc., T. +1.647.362.4684, [email protected], www.moleculight.com
Photo - https://mma.prnewswire.com/media/2264598/MolecuLight_12_Posters_and_Presentations_Featuring_MolecuLight_t.jpg
Photo - https://mma.prnewswire.com/media/2264599/MolecuLight_12_Posters_and_Presentations_Featuring_MolecuLight_t.jpg
SOURCE MolecuLight Inc.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.